26/06/2026
Obesity rarely occurs on its own. It is often linked to conditions like Type 2 diabetes, fatty liver disease, and cardiovascular disease and addressing weight can have a meaningful impact on all of them.
For some patients, medications such as Semaglutide and Tirzepatide may be part of a broader, individualised strategy to reduce long-term health risks, not just support weight loss. Every person's journey is different, and finding the right approach takes time, care, and the right support.
Want to understand whether these medications are right for you, or what the next step looks like? Read the full article: https://aspenendocrine.com/a-new-era-of-weight-loss-medications/
Reach out to Dr Anuradha Negi, Consultant Endocrinologist, to learn more.
📧 [email protected]
📞 +65 8907 8973
🌐 www.aspenendocrine.com